药物诱导的自身免疫性肝炎:仍有许多未解答的问题
Fernando Bessone1, Einar S Bjornsson2
1Department of Gastroenterology and Hepatology, Facultad de Ciencias Médicas, Hospital Provincial del Centenario, University of Rosario School of Medicine, Rosario 2000, Santa Fe, Argentina. bessonefernando@gmail.com.
World journal of hepatology
|December 10, 2025
概括
药物诱导的自身免疫性肝炎 (DI-ALH) 在与经典自身免疫性肝炎 (AIH) 区分方面存在挑战. 虽然DI-ALH通常对皮质类固醇有反应,并且有良好的预后,但需要仔细监测.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 药物诱导的自身免疫性肝炎 (DI-ALH) 是一种新兴的药物诱导的肝损伤类型.
- DI-ALH 与经典的自身免疫性肝炎 (AIH) 有共同的特征,使诊断复杂化.
- 众所周知,几种药物可诱导DI-ALH,包括尼托福兰和因弗利西马布.
研究的目的:
- 审查目前对DI-ALH的理解.
- 讨论诊断挑战和管理策略.
- 为突出 DI-ALH 的未来研究方向.
主要方法:
- 关于DI-ALH和AIH的文学评论.
- 对临床,生化和组织学特征的分析.
- 治疗反应和预后的比较.
主要成果:
- DI-ALH和AIH表现出重叠的特征,使得区分变得困难.
- DI-ALH 经常对皮质类固醇有好反应,在戒药后复发率低.
- 存在组织学差异,在经典AIH中纤维化患病率较高.
结论:
- 准确区分DI-ALH和AIH对于适当的管理至关重要.
- 虽然DI-ALH通常有良好的预后,但需要长期的随访.
- 需要进一步的国际合作,以充分表征DI-ALH.
相关概念视频
Autoimmune Disorders
1.4K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
1.4K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
169
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
169
Hepatic Drug Excretion: Enterohepatic Cycling
2.5K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
2.5K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
200
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
200
Allergic Drug Reactions
1.3K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K
Gastritis-II: Pathophysiology
1.1K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.1K


